{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:55:18Z","timestamp":1775796918060,"version":"3.50.1"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Maternal humoral immunity appears to confer protection to infants against SARS-CoV-2. However, data comparing the protective effect of naturally acquired versus vaccine-induced maternal immunity in infants remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A retrospective observational study was conducted in infants \u22646 months of age with suspected infection between January 2021 and September 2024. The sample was divided into those with confirmed SARS-CoV-2 infection and those with a negative microbiological result for the virus. The association between maternal serology (anti-S1-RBD IgG), the origin of maternal immunity and symptomatic SARS-CoV-2 infection in infants was analyzed, adjusting for infant age and month of infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 244 infants were included, of whom 22% had confirmed SARS-CoV-2 infection. Anti-S1-RBD IgG antibodies were detected in 76.2% of mothers, and their presence was associated with a lower risk of infection in infants [relative risks (RR): 0.459; 95% confidence interval (95% CI): 0.284\u20130.744;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.002]. Naturally acquired immunity showed a stronger protective effect (RR: 0.397; 95% CI: 0.213\u20130.744;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.004) compared with vaccine-induced immunity (RR: 0.558; 95% CI: 0.325\u20130.958;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.034). Maternal antibody titers demonstrated limited predictive capacity for infant protection (area under the curve = 0.699), with an optimal threshold of 109.50 BAU\/mL (sensitivity 68.5%, specificity 73%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The presence of maternal anti-S1-RBD IgG antibodies was associated with a lower risk of SARS-CoV-2 infection in infants \u22646 months old, with a more pronounced effect from natural maternal immunity. However, its predictive value was limited, suggesting that additional immunological factors may contribute to infant susceptibility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/inf.0000000000005085","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T05:00:20Z","timestamp":1765947620000},"page":"457-461","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Protective Role of Maternal Antibodies Against SARS-CoV-2 in Infants Six Months or Younger: An Observational Study"],"prefix":"10.1097","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8255-7093","authenticated-orcid":false,"given":"Elena","family":"Porras L\u00f3pez","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Neonatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blanca","family":"Elices R\u00edos","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Neonatology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Emilio","family":"Losa Garcia","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Goyanes Gal\u00e1n","sequence":"additional","affiliation":[{"name":"Clinical Microbiology Department"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2726-8683","authenticated-orcid":false,"given":"Elia","family":"P\u00e9rez Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Research Unit, Hospital Universitario Fundaci\u00f3n Alcorc\u00f3n, Alcorc\u00f3n"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6732-733X","authenticated-orcid":false,"given":"Mercedes","family":"Bueno Campa\u00f1a","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Neonatology"},{"name":"IdiPAZ Research Institute, Translational Research Network for Paediatric Infectious Diseases (RITIP)"},{"name":"Centre for Biomedical Research in Infectious Diseases (CIBERINFEC), Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,12,17]]},"reference":[{"key":"R1-20260410","doi-asserted-by":"crossref","first-page":"126123","DOI":"10.1016\/j.vaccine.2024.07.024","article-title":"Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: a prospective cohort study.","volume":"42","author":"Korchinski","year":"2024","journal-title":"Vaccine"},{"key":"R2-20260410","doi-asserted-by":"crossref","first-page":"e053036","DOI":"10.1136\/bmjopen-2021-053036","article-title":"Passive and active immunity in infants born to mothers with SARS-CoV-2 infection during pregnancy: prospective cohort study.","volume":"11","author":"Song","year":"2021","journal-title":"BMJ Open"},{"key":"R3-20260410","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/phar.2649","article-title":"Role of maternal COVID\u201019 vaccination in providing immunological protection to the newborn.","volume":"42","author":"Jorgensen","year":"2022","journal-title":"Pharmacotherapy"},{"key":"R4-20260410","doi-asserted-by":"crossref","first-page":"100492","DOI":"10.1016\/j.ajogmf.2021.100492","article-title":"Maternal-neonatal transfer of SARS-CoV-2 immunoglobulin G antibodies among parturient women treated with BNT162b2 messenger RNA vaccine during pregnancy.","volume":"4","author":"Nir","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R5-20260410","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2204399","article-title":"Maternal vaccination and risk of hospitalization for covid-19 among infants.","volume":"387","author":"Halasa","year":"2022","journal-title":"N Engl J Med"},{"key":"R6-20260410","doi-asserted-by":"crossref","first-page":"264","DOI":"10.15585\/mmwr.mm7107e3","article-title":"Effectiveness of maternal vaccination with mRNA COVID-19 vaccine during pregnancy against COVID-19\u2013associated hospitalization in infants aged <6 Months\u201417 States, July 2021\u2013January 2022.","volume":"71","author":"Halasa","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R7-20260410","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1038\/s41372-021-01216-1","article-title":"Titers of SARS CoV-2 antibodies in cord blood of neonates whose mothers contracted SARS CoV-2 (COVID-19) during pregnancy and in those whose mothers were vaccinated with mRNA to SARS CoV-2 during pregnancy.","volume":"41","author":"Kashani-Ligumsky","year":"2021","journal-title":"J Perinatol"},{"key":"R8-20260410","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3390\/v14010085","article-title":"Evaluation of clinical and immune responses in recovered children with mild COVID-19.","volume":"14","author":"Tian","year":"2022","journal-title":"Viruses"},{"key":"R9-20260410","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/s41467-021-21444-5","article-title":"Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19.","volume":"12","author":"Wheatley","year":"2021","journal-title":"Nat Commun"},{"key":"R10-20260410","doi-asserted-by":"crossref","first-page":"e157354","DOI":"10.1172\/jci.insight.157354","article-title":"Neutralizing antibody activity against SARS-CoV-2 variants in gestational age\u2013matched mother-infant dyads after infection or vaccination.","volume":"7","author":"Matsui","year":"2022","journal-title":"JCI Insight"},{"key":"R11-20260410","doi-asserted-by":"crossref","first-page":"e150319","DOI":"10.1172\/JCI150319","article-title":"Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine.","volume":"131","author":"Beharier","year":"2021","journal-title":"J Clin Invest"},{"key":"R12-20260410","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejca.2021.12.011","article-title":"Third dose of anti-SARS-CoV-2 vaccine for patients with cancer: should humoral responses be monitored? A position article.","volume":"162","author":"Barri\u00e8re","year":"2022","journal-title":"Eur J Cancer (Oxford, England : 1990)"},{"key":"R13-20260410","doi-asserted-by":"crossref","first-page":"e0289713","DOI":"10.1371\/journal.pone.0289713","article-title":"Correlation of a commercial platform\u2019s results with post-vaccination SARS-CoV-2 neutralizing antibody response and clinical host factors. Harapan H, ed.","volume":"18","author":"Slotkin","year":"2023","journal-title":"PLoS One"},{"key":"R14-20260410","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s15010-020-01503-7","article-title":"A highly specific and sensitive serological assay detects SARS-CoV-2 antibody levels in COVID-19 patients that correlate with neutralization.","volume":"49","author":"Peterhoff","year":"2021","journal-title":"Infection"},{"key":"R15-20260410","doi-asserted-by":"crossref","first-page":"e0281257","DOI":"10.1371\/journal.pone.0281257","article-title":"Anti-spike protein to determine SARS-CoV-2 antibody levels: is there a specific threshold conferring protection in immunocompromised patients? Guven DC, ed.","volume":"18","author":"Halfon","year":"2023","journal-title":"PLoS One"},{"key":"R16-20260410","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/jama.2022.1206","article-title":"Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural Infection.","volume":"327","author":"Shook","year":"2022","journal-title":"JAMA"},{"key":"R17-20260410","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1093\/infdis\/jiad592","article-title":"Hybrid immunity to SARS-CoV-2 during pregnancy provides more durable infant antibody responses compared to natural infection alone.","volume":"229","author":"LaCourse","year":"2024","journal-title":"J Infect Dis"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005085","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T04:00:55Z","timestamp":1775793655000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000005085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,17]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000005085","relation":{},"ISSN":["0891-3668","1532-0987"],"issn-type":[{"value":"0891-3668","type":"print"},{"value":"1532-0987","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,17]]}}}